Pulmonx Corporation (LUNG)
undefined
undefined%
At close: undefined
6.55
-0.02%
After-hours Jan 03, 2025, 04:00 PM EST

Company Description

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases.

It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.

The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.

It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally.

The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.

Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Pulmonx Corporation
Pulmonx Corporation logo
Country United States
IPO Date Oct 1, 2020
Industry Medical - Devices
Sector Healthcare
Employees 279
CEO Steven S. Williamson

Contact Details

Address:
700 Chesapeake Drive
Redwood City, California
United States
Website https://pulmonx.com

Stock Details

Ticker Symbol LUNG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001127537
CUSIP Number 745848101
ISIN Number US7458481014
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Steven S. Williamson Chief Executive Officer, President & Director
Lisa Paul Chief People Officer
Mehul Joshi Chief Financial Officer
David A. Lehman J.D. General Counsel & Secretary
Geoffrey Beran Rose Chief Commercial Officer
John B. McKune Vice President & Corporate Controller
Jérôme Erath Senior Vice President & GM of Europe Middle-East & Africa
Marcee M. Maroney Vice President of Marketing
Sarah Huber Vice President of Sales (U.S.)
Sri Radhakrishnan Chief Technical Officer

Latest SEC Filings

Date Type Title
Dec 04, 2024 4 Filing
Dec 04, 2024 4 Filing
Nov 26, 2024 4 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 01, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Oct 21, 2024 4 Filing
Sep 18, 2024 4 Filing